Literature DB >> 25111912

Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.

Kimihiko Moriya1, Takahiko Mitsui2, Takeya Kitta2, Michiko Nakamura2, Yukiko Kanno2, Masafumi Kon2, Yoko Nishimura2, Nobuo Shinohara2, Katsuya Nonomura2.   

Abstract

PURPOSE: We retrospectively assessed the incidence of and risk factors for febrile urinary tract infection in children during active surveillance after early discontinuation of antibiotic prophylaxis.
MATERIALS AND METHODS: We retrospectively evaluated 9 females and 61 uncircumcised males diagnosed with primary vesicoureteral reflux before age 1 year who had persistent reflux on followup voiding cystourethrogram and were subsequently followed under active surveillance without continuous antibiotic prophylaxis. Patients with secondary vesicoureteral reflux or associated urological abnormality were excluded. Clinical outcomes, including incidence of febrile urinary tract infection and new scar formation, were evaluated. Risk factors for febrile urinary tract infection were also analyzed.
RESULTS: Mean age at stopping continuous antibiotic prophylaxis was 21 months, and mean followup was 61 months. During active surveillance 21 patients had febrile urinary tract infection, and the 5-year infection-free rate under active surveillance was 67.5%. One or 2 foci of minimal new scarring developed in 4 of 16 patients who underwent followup dimercapto-succinic acid scan after febrile urinary tract infection. On multivariate analysis dilated vesicoureteral reflux on followup voiding cystourethrogram was the only significant risk factor for febrile urinary tract infection.
CONCLUSIONS: This study revealed that about two-thirds of patients with persistent vesicoureteral reflux were free of febrile urinary tract infection during 5 years of active surveillance. Those with dilated vesicoureteral reflux on followup voiding cystourethrogram are at significantly greater risk for febrile urinary tract infection. Accordingly active surveillance, especially in patients with nondilated vesicoureteral reflux on followup voiding cystourethrogram, seems to be a safe option even in children who have not yet been toilet trained.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  risk factors; urinary tract infections; vesico-ureteral reflux; watchful waiting

Mesh:

Year:  2014        PMID: 25111912     DOI: 10.1016/j.juro.2014.08.007

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Vesicoureteral reflux: From prophylaxis to surgery.

Authors:  Anne-Sophie Blais; Stéphane Bolduc; Katherine Moore
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  Postnatal imaging of prenatally detected hydronephrosis-when is voiding cystourethrogram necessary?

Authors:  Sofia Visuri; Reetta Kivisaari; Timo Jahnukainen; Seppo Taskinen
Journal:  Pediatr Nephrol       Date:  2018-04-07       Impact factor: 3.714

3.  Urinary microprotein concentrations in the long-term follow-up of dilating vesicoureteral reflux patients who underwent medical or surgical treatment.

Authors:  Jialu Liu; Hong Xu; Qian Shen; Yunli Bi; Xiang Wang; Li Sun; Jia Rao
Journal:  Int Urol Nephrol       Date:  2015-11-11       Impact factor: 2.370

4.  Girls and renal scarring as risk factors for febrile urinary tract infection after stopping antibiotic prophylaxis in children with vesicoureteral reflux.

Authors:  Michiko Nakamura; Kimihiko Moriya; Masafumi Kon; Yoko Nishimura; Hiroki Chiba; Takeya Kitta; Nobuo Shinohara
Journal:  World J Urol       Date:  2021-01-03       Impact factor: 4.226

5.  Guidelines for the medical management of pediatric vesicoureteral reflux.

Authors:  Hideshi Miyakita; Yutaro Hayashi; Takahiko Mitsui; Manabu Okawada; Yoshiaki Kinoshita; Takahisa Kimata; Yasuhiro Koikawa; Kiyohide Sakai; Hiroyuki Satoh; Masatoshi Tokunaga; Yasuyuki Naitoh; Fumio Niimura; Hirofumi Matsuoka; Kentaro Mizuno; Kazunari Kaneko; Masayuki Kubota
Journal:  Int J Urol       Date:  2020-04-01       Impact factor: 3.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.